CS logo
small CS logo
Royal Devon and Exeter Hospital (Wonford)

Exeter, United Kingdom
Hospital in Exeter, England
Barrack Rd, Exeter EX2 5DW

About Royal Devon and Exeter Hospital (Wonford)


The Royal Devon and Exeter Hospital, is a large teaching hospital situated in Exeter, Devon, England. The hospital has two sites, situated in Wonford and Heavitree, Exeter, and is part of the Royal Devon and Exeter NHS Foundation Trust.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
12
Celgene
4
Takeda
3
Daiichi Sankyo, Inc.
2
Millennium Pharmaceuticals, Inc.
2
Bial - Portela C S.A.
1
EMD Serono Research & Development Institute, Inc.
1
Ferring Pharmaceuticals
1
ImmunoGen, Inc.
1
Medical Developments International Limited
1
ReCor Medical, Inc.
1
Total Rows: 13

Clinical Trials at Royal Devon and Exeter Hospital (Wonford)


During the past decade, Royal Devon and Exeter Hospital (Wonford) conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 17 clinical trials were completed, i.e. on average, 68% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 12 clinical trials were completed. i.e. 400% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years8888223311112200111111224455Started TrialsCompleted Trails20152016201720182019202020210246810
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-09-20
2022-12-30
Completed
835
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
2012-08-27
2017-11-21
Completed
481
A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors
2014-05-21
2020-04-16
Completed
609
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors
2014-12-24
2020-06-23
Completed
397
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
2015-03-20
2021-09-07
Completed
1,035
Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)
2015-03-24
2019-12-03
Completed
792
Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
2015-06-08
2026-05-21
Active, not recruiting
900

Rows per page:

1–31 of 31

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Royal Devon and Exeter Hospital (Wonford)" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Celgene" with 4 trials sponsored, "Takeda" with 3 trials sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored and "Millennium Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Devon and Exeter Hospital (Wonford)" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "European Network of Individualized Treatment in Endometrial Cancer - ENITEC" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 12Hoffmann-La Roche: 12Celgene: 4Celgene: 4Takeda: 3Takeda: 3Daiichi Sankyo, Inc.: 2Daiichi Sankyo, Inc.: 2MillenniumPharmaceuticals, Inc.: 2MillenniumPharmaceuticals, Inc.: 2Bial - Portela C S.A.: 1Bial - Portela C S.A.: 1EMD Serono Research &Development Institute,Inc.: 1EMD Serono Research &Development Institute,Inc.: 1Ferring Pharmaceuticals: 1Ferring Pharmaceuticals: 1ImmunoGen, Inc.: 1ImmunoGen, Inc.: 1Medical DevelopmentsInternational Limited: 1Medical DevelopmentsInternational Limited: 1

Created with Highcharts 11.1.0Top CollaboratorsAstraZeneca: 2AstraZeneca: 2Daiichi Sankyo Co., Ltd.: 2Daiichi Sankyo Co., Ltd.: 2Duke Clinical ResearchInstitute: 1Duke Clinical ResearchInstitute: 1European Network ofGynaecologicalOncological Trial Groups(ENGOT): 1European Network ofGynaecologicalOncological Trial Groups(ENGOT): 1European Network ofIndividualizedTreatment inEndometrial Cancer -ENITEC: 1European Network ofIndividualizedTreatment inEndometrial Cancer -ENITEC: 1European Network ofTranslational Researchin Ovarian Cancer -EUTROC: 1European Network ofTranslational Researchin Ovarian Cancer -EUTROC: 1Gynecologic Oncology Group: 1Gynecologic Oncology Group: 1Memorial SloanKettering CancerCenter: 1Memorial SloanKettering CancerCenter: 1Merck KGaA,Darmstadt, Germany: 1Merck KGaA,Darmstadt, Germany: 1Pediatric EmergencyResearch in the UK andIreland (PERUKI): 1Pediatric EmergencyResearch in the UK andIreland (PERUKI): 1

Clinical Trials Conditions at Royal Devon and Exeter Hospital (Wonford)


According to Clinical.Site data, the most researched conditions in "Royal Devon and Exeter Hospital (Wonford)" are "Ulcerative Colitis" (5 trials), "Crohn Disease" (3 trials), "Crohn's Disease" (3 trials), "Breast Cancer" (2 trials) and "Colitis, Ulcerative" (2 trials). Many other conditions were trialed in "Royal Devon and Exeter Hospital (Wonford)" in a lesser frequency.

Clinical Trials Intervention Types at Royal Devon and Exeter Hospital (Wonford)


Most popular intervention types in "Royal Devon and Exeter Hospital (Wonford)" are "Drug" (27 trials), "Biological" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Etrolizumab" (4 trials), "Ocrelizumab" (3 trials), "Paclitaxel" (3 trials) and "GED-0301" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Royal Devon and Exeter Hospital (Wonford)


The vast majority of trials in "Royal Devon and Exeter Hospital (Wonford)" are 28 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Royal Devon and Exeter Hospital (Wonford)


Currently, there are NaN active trials in "Royal Devon and Exeter Hospital (Wonford)". undefined are not yet recruiting, 3 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Royal Devon and Exeter Hospital (Wonford), undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Royal Devon and Exeter Hospital (Wonford), 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 23Phase 3: 23Phase 2: 3Phase 2: 3Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 15Completed: 15Active, not recruiting: 10Active, not recruiting: 10Recruiting: 3Recruiting: 3Terminated: 3Terminated: 3